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Background Despite widespread condom promotion for HIV prevention, prospec-
tive measurement of condom use before and after HIV testing is
infrequent.
Methods We analysed data from a prospective study of hormonal con-
traception and HIV acquisition among Zimbabwean and Ugandan
women (1999–2004), in which HIV testing and counselling were
performed approximately every 3 months. We used zero-inflated
negative binomial (ZINB) models to examine the number and pro-
portion of unprotected sex acts, comparing behaviour reported 2–6
months before HIV testing with behaviour reported both 2–6
months (short-term analysis) and 12–16 months (long-term analy-
sis) after HIV testing.
Results Short- and long-term analyses were similar, so we present
only long-term findings from 151 HIV-infected and 650 uninfected
participants. The proportion of HIV-infected women reporting
any unprotected acts in a typical month declined from 74% (pre-
infection behaviour) to 56% (12–16 months after HIV diagnosis). In
multivariable models, HIV-infected women were twice as likely to
report that all sex acts were protected by condoms after diagnosis
compared with beforehand [adjusted odds ratio (aOR): 1.99, 95%
confidence interval (CI): 1.12–3.53]; uninfected women were some-
what less likely to report that all acts were protected (aOR: 0.82,
95% CI: 0.64–1.04). HIV-infected women also reduced their number
of unprotected acts by 38% (95% CI: 16 to 55%). However, their
proportion of unprotected acts changed little (7% reduction, 95% CI:
18 to þ 6%). Uninfected women reported little change in number
or proportion of unprotected acts over the same time period.
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Conclusions HIV-infected women reduced the number, but not the proportion,
of unprotected acts. HIV-negative women did not increase condom
use after testing and counselling, but neither did they decrease
condom use, suggesting that testing negative was not interpreted
as endorsement of risky behaviour.
Keywords Zero-inflated, negative binomial, HIV/AIDS, male condom, risk
behaviour, positive prevention, women, Uganda, Zimbabwe, unpro-
tected sex
Introduction
Recent prevention initiatives for human immunodefi-
ciency virus (HIV) focus on ‘positive prevention’––
targeting and supporting HIV-infected individuals to
modify their behaviour and consequently reduce the
risk of future transmission.1–4 Whether among
infected or uninfected individuals, HIV prevention
interventions typically include counselling on the
use of male condoms.5 However, few studies have
prospectively measured condom use before and after
notification of HIV status in African women. In a
longitudinal voluntary counselling and testing inter-
vention in rural Zimbabwe,6 3 years after HIV testing,
HIV-infected women (but not men) reported more
consistent condom use with their primary partners.
Little change in condom use was observed in partici-
pants testing HIV-negative at baseline, though these
individuals reported increases in other risky sexual
behaviours.6
In the absence of other strictly comparable prospec-
tive studies on condom use before and after knowl-
edge of HIV status, we reviewed cross-sectional
reports of repeat HIV testing. Among Senegalese
female sex workers, those who self-reported a pre-
vious negative HIV test were significantly less likely
to use condoms consistently with primary partners
than women with no previous HIV testing; those
who reported a previous positive test were also some-
what less likely to use condoms with primary part-
ners.7 Previous testing did not affect condom use
with clients.7 A London study reported that repeat
(compared with first-time) male testers were more
likely to report unprotected sex with two or more
partners in the previous 6 months; there was no asso-
ciation for women between repeat testing and
condom use.8 A second cross-sectional study in the
same clinic found no significant associations between
repeat HIV testing and condom use except among
homosexual men with three or more previous HIV
tests.9
Several condom promotion interventions have com-
pared condom use after the intervention to behaviour
reported at the time of the intervention, or to a con-
trol group. A meta-analysis of HIV prevention studies
from 1985 to 1997 found that the benefits of condom
counselling (including increases in condom use) were
more apparent in those testing HIV-positive than
those testing negative.10 Another review found that
reported condom use and abstinence increased over
time in HIV-infected women receiving counselling,
and that HIV-infected individuals are more likely
than HIV-uninfected individuals to use condoms.11
Is notification of HIV status, together with repeat
risk reduction counselling, sufficient to induce and
maintain increased condom use? We aimed to assess
the effect of notification of HIV-positive status
on African women’s use of condoms 2–6 months
after diagnosis and 12–16 months after diagnosis,
compared with their pre-diagnosis behaviour.
Because a negative HIV test may be interpreted as
endorsement of risky behaviour,6–9 we also assessed
the effect of notification of HIV-negative status on
condom use among uninfected participants over the
same time periods.
Methods
This analysis draws data from the ‘Hormonal
Contraception and Risk of HIV Acquisition’
(HC-HIV) study, a prospective cohort study conducted
in Uganda, Zimbabwe and Thailand, and an ancillary
study called the ‘Effect of Hormonal Contraception on
HIV Genital Shedding and Disease Progression among
Women with Primary HIV Infection’ (GS) study.
HC-HIV assessed the effect of hormonal contraception
on women’s HIV risk; detailed methods and main
findings have been published elsewhere.12 GS fol-
lowed Ugandan and Zimbabwean women who
became HIV infected during HC-HIV.
Study setting and population
The HC-HIV study followed women from 1999 to
2004. All Zimbabwean and most Ugandan partici-
pants were recruited from family planning and
maternal-child health clinics. Owing to low initial
HIV incidence rates among Ugandan women, recruit-
ment there was expanded to include referrals
from ‘higher-risk’ populations, such as sexually trans-
mitted disease (STD) clinics, sex workers and military
wives. Eligible women were 18–35 years of age; HIV-
uninfected; sexually active and using either oral con-
traceptive pills, injectable depot medroxyprogesterone
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acetate, or a non-hormonal or no contraceptive
method. The 24-month retention rate for participants
in the HC-HIV study was 92%: 96% in Uganda and
88% in Zimbabwe.
Starting in March 2001, all women in Zimbabwe
and Uganda who became HIV infected during
HC-HIV were invited to enrol in GS. Because few
incident HIV infections occurred in Thailand, the




At enrolment and each follow-up visit, women
received face-to-face interviews about their reproduc-
tive, contraceptive and sexual behaviour, including
condom use. All HIV pre- and post-test counselling
sessions included instructions on condom use. Visits
took place approximately every 3 months for up to
2 years or until HIV seroconversion.
GS study
Women who became HIV infected during HC-HIV
were told about GS; interested women returned
for GS enrolment. Follow-up visits during GS took
place, as in HC-HIV, approximately quarterly. At
each GS visit the same face-to-face HC-HIV question-
naires were administered to collect reproductive
and sexual behaviour data; women also underwent
physical examinations with specimen collection.
Beginning in June 2003, all GS participants
who met specific criteria were offered highly active
antiretroviral therapy (HAART). The GS study used
the standard World Health Organization (WHO) cri-
teria for HAART initiation in resource-poor countries
(WHO Clinical Stage 4 or severe Clinical Stage 3 dis-
ease or two successive CD4 counts4 200 cells).
Counselling
Hormonal contraceptive counselling and condom
counselling were performed by trained counsellors
during both HC-HIV and GS.
In HC-HIV, contraceptive counselling was conducted
at each visit only for women using hormonal meth-
ods. In GS, all non-pregnant women (regardless of
current contraceptive use) were counselled about the
most effective methods of contraception, including
hormonal options.
All women in both studies received condom coun-
selling at each visit. Condom counselling included a
demonstration of condom use using a wooden model,
the opportunity for participants to practise using male
condoms on the model, instructions to use male
or female condoms to prevent sexually transmitted
infection (STI)/HIV acquisition (and in GS, HIV trans-
mission), and information on condom negotiation. All
participants in both studies were given condoms to
take home at each visit. Condom counselling followed
the same general script for women in HC-HIV and
GS, with a slightly extended session for HIV-positive
women. The content and intensity of condom coun-
selling were similar for HIV-positive and HIV-negative
women.
Counselling sessions were comparable to expanded
counselling sessions in a clinical context, and lasted
30 min for HIV-negative women and 45 min for HIV-
infected women. Prior to initiation of the study, coun-
sellors underwent training sessions that involved
rehearsing the counselling script and role playing.
HIV-positive and HIV-negative participants were
counselled at every visit that their partners could
be counselled and tested free of charge at the study
clinic, and study counsellors offered to help HIV-
infected women to tell their partners of their serosta-
tus. However, we did not systematically collect data
on how often couples were counselled together, how
often male partners came to the clinic for counselling
and testing, and whether women chose to inform
their partners of their serostatus.
Study counsellors discussed prevention of mother-
to-child transmission (PMTCT) of HIV with HIV-
infected women at their regular counselling sessions.
If a participant became pregnant and met the specific
GS study criteria for antiretroviral therapy, she was
given the study regimen for pregnant women. If she
did not meet GS study criteria, she was referred
immediately to local PMTCT programmes.
Statistical analyses
Exposure measure: notification of HIV-positive status
Participants received HIV test results at every HC-HIV
visit using a combination of two enzyme-linked
immunosorbent (EIA) assays or rapid tests. Positive
results were confirmed by western blot or HIV DNA or
RNA polymerase chain reaction (PCR) tests. The full
HIV testing algorithm and specific tests used are
described elsewhere.12 None of the HIV tests (rapid,
EIA, western blot or PCR tests) was performed at the
clinic where participants’ blood was drawn. Blood was
sent to the laboratories and when positive results
were received at the clinic, participants were called
back for a confirmatory blood draw 10–21 days after
the initial test (results were normally received within
10 days, but it sometimes took women up to 3 weeks
to return to the clinic for their results and confirma-
tory redraw visit). At the redraw visit, counsellors
informed the woman that her HIV test appeared posi-
tive, but that further confirmatory tests were needed.
Final results were typically given to women within
2 weeks. We used the date of the redraw visit as
the date of diagnosis.
Outcome measure: number of unprotected sex
acts in a typical month
At each visit, during both HC-HIV and GS, partici-
pants were asked: ‘In the last 3 months, in a typical
month, how many times did you have sex?’ And ‘In
the last 3 months, in a typical month, how many
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times did your partner use a male condom during sex
with you?’ Women answered these questions sepa-
rately for primary and other partners. Women were
given clarification that ‘sex’ referred to vaginal sex,
and interviewers informed women that a ‘typical
month’ referred to the month since their last study
visit that they considered the most ‘average’ (of the
3 months in question) in terms of the frequency of
sex. The number of unprotected acts in a typical
month was calculated as the total number of acts
with all partners minus the total number of acts
where condoms were used.
Analytic procedures
We examined condom use in two analyses, by merg-
ing data collected during HC-HIV with data collected
during GS. We constructed pairs of observations for
each participant, with one ‘before’ and one ‘after’
measure. Statistical analyses were performed using
SAS (Version 9.1.3, SAS Institute, Cary, NC) and
Stata (Version 9.2, Statacorp, College Station, TX).
Short-term comparison
Our first analysis examined short-term changes in
participants’ self-reported condom use. For women
who acquired HIV during HC-HIV, we selected
one HC-HIV visit 2–6 months prior to notification
of HIV-positive status (the ‘before’ visit) and one GS
visit 2–6 months after HIV diagnosis (‘after’ visit). For
women who remained HIV uninfected, we randomly
selected a visit at which she received a negative
HIV result using SAS’s random number generator
(her ‘anchor’ visit). We then chose corresponding
visits 2–6 months before and 2–6 months after the
anchor visit. From all uninfected women with visits
within the specified timeframe, we randomly selected
a sample in an approximate 4 : 1 ratio with HIV-
infected women.
Long-term comparison
We also examined changes in self-reported condom
use over a longer time period. For women who
became HIV infected, we again selected one HC-HIV
visit 2–6 months prior to notification of HIV-positive
status, but we paired it with one GS visit 12–16
months after HIV diagnosis. For women remaining
uninfected, we chose corresponding visits 2–6
months before the randomly selected anchor visit
and 12–16 months after the anchor visit. We again
randomly selected a sample of uninfected women in
an approximate 4 : 1 ratio with HIV-infected
participants.
Comparisons of coital frequency and
unprotected sex
Using McNemar’s test,13 we examined whether the
number of women reporting any sex in a typical
month, or the number reporting any unprotected
acts, changed a short and longer period after HIV
testing, separately for HIV-infected and uninfected
women.
Multivariable models
Because the outcome––number of acts where con-
doms were not used––is a count, we assessed various
model types for count data, including the Poisson,
negative binomial (NB), zero-inflated Poisson and
zero-inflated negative binomial (ZINB) distribu-
tions.14–16 We graphically compared the predicted
probabilities of the count outcomes produced by
each model type to the observed count data. We
assessed fit using the likelihood ratio test (to compare
the Poisson model to the NB model) and the Vuong
test (to compare the ZINB model with the NB
model).17 ZINB models provided the best fit. We ran
each ZINB multivariable model without and then
with an offset variable capturing the total number
of acts in a typical month.
ZINB models produce two sets of parameter esti-
mates. First, a logistic procedure yields an odds ratio
(OR): this OR compares the odds of having no unpro-
tected acts in a typical month after HIV diagnosis
(for HIV-positive women) or anchor visit (uninfected
women) with the odds of having no unprotected
acts in a typical month beforehand: in other words,
the odds of all acts being protected by condoms in a
typical month after HIV diagnosis or anchor visit
compared with the odds all acts being protected in
a typical month before diagnosis or anchor visit.
A second set of parameter estimates is produced by
the NB procedure. Without an offset variable, the NB
effect estimate represents the relative change in the
number of unprotected acts in a typical month after
HIV diagnosis or anchor visit, compared with the
number of unprotected acts in a typical month before-
hand. When including an offset variable, the NB esti-
mate is the relative change in the proportion of acts in
a typical month where condoms were not used.
To generate separate effect estimates for HIV-
infected and uninfected participants, we used three
independent variables: HIV, coded 0 for women who
remained HIV negative and 1 for women who became
HIV infected; timepoint, coded 0 for visits prior to HIV
testing and 1 for visits after; and a product-interac-
tion term between timepoint and HIV.
We used a Directed Acyclic Graph (DAG)18 to identify
variables that could confound the association between
HIV testing and condom use. Following DAG analysis,
variables assessed in preliminary analyses prior to the
multivariable modelling phase included age, age at
coital debut, education, nights the primary partner
was away from home in the previous 30 days, cohabita-
tion, employment status of the woman and her primary
partner, alcohol and drug use in the previous 3 months,
commercial sex in the previous 3 months, number of
partners in the previous 3 months, country and referral
population (Uganda high-risk vs Uganda low-risk vs
Zimbabwe), prior STI in the study period and
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circumcision status of the primary sex partner. We
included in each starting multivariable model all factors
that were associated with HIV status or condom use.
Age was the only variable forced into the models. Prior
literature indicated that age is associated with becom-
ing HIV infected and with changes in risk behaviour
generally. We assessed continuous variables graphically
by examining the linearity of the log risk of the outcome
according to incremental categories of each continuous
variable. We did not include hormonal contraceptive
use in the models, because contraception could be
affected by notification of HIV status.19 (The measures
of effect did not change measurably when hormonal
contraception was excluded for this methodological
reason.) We used robust variance estimation to account
for non-independence resulting from repeated mea-
sures on individual participants; we implemented this
in Stata by specifying the ‘robust’ option, with partici-
pant as the repeated observation. 20,21
To construct final models, we used a backward
elimination, change-in-estimate strategy.22 One by
one, we manually removed covariates from the start-
ing model, beginning with the variable leading
to the smallest change in the association of interest;
if removal changed the condom use association
by < 10%, a given covariate was not retained.
We designated models as ‘final’ when the remaining
covariates confounded the main association or were
retained for a priori considerations (age).
Any covariate that confounded the estimate for HIV-
infected participants or for uninfected women, in
either short- or long-term analyses, in the logistic
or NB portions of the model, or in a model with or
without the offset variable, was included in the final
adjustment set for all analyses.
Ethical approval
All women enrolled in HC-HIV and GS gave written
informed consent prior to participating, and local
ethics committees at collaborating institutions gave
approval for the studies.
Results
Short-term changes in self-reported
condom use
Selection of HIV-infected and uninfected participants
Of 213 Ugandan and Zimbabwean women who
became HIV infected during HC-HIV, 191 (90%)
eventually participated in GS. A smaller proportion,
74% (n¼ 158) had a GS visit 2–6 months after HIV
diagnosis and are included in the short-term compar-
ison. For these 158 participants, the median time
between the ‘before’ visit and the redraw visit was
3.3 months [interquartile range (IQR): 2.8–3.9
months], and the median time between the redraw
visit and the ‘after’ visit was 2.7 months (IQR: 2.3–3.7
months). We observed no meaningful differences
between characteristics of HIV-infected women choos-
ing and declining to enrol in GS (data not shown).
From 4226 HC-HIV participants who remained
HIV uninfected, 650 women were randomly selected
for the short-term analysis. For these uninfected
women, the median time between the ‘before’ visit
and the anchor visit was 2.7 months (IQR: 2.6–2.8
months), and between the anchor visit and the ‘after’
visit was also 2.7 months (IQR: 2.6–2.9 months).
Because participant characteristics (Table 1),
changes in frequencies of coitus and unprotected
sex (Table 2), and results of multivariable models
(Tables 3 and 4) for short-term comparisons were
similar to long-term analyses, we describe only long-
term findings in detail (below).
Long-term changes in self-reported condom
use
Selection of HIV-infected and uninfected participants
Of 191 HIV-infected women who joined GS, 151 par-
ticipants (79% of GS participants and 71% of
HIV-infected HC-HIV participants) had a GS visit
12–16 months after HIV diagnosis. For these
women, the median time between the ‘before’ visit
and the redraw visit was 3.2 months (IQR: 2.7–3.7
months), and the median time between the redraw
visit and the ‘after’ visit was 13.8 months (IQR: 13.1–
14.3 months). Uninfected women (n¼ 650) for the
long-term comparison were randomly selected from
the 4226 HC-HIV participants who remained HIV-
uninfected, independent of inclusion in the short-
term analysis. The median time between the ‘before’
visit and the anchor visit for uninfected women in the
long-term comparison was 2.7 months (IQR: 2.6–2.9
months), and between the anchor visit and ‘after’
visit was 13.5 months (IQR: 13.1–14.0 months).
Most HIV-infected women in the long-term analysis
(91%, n¼ 137) were also included in the short-term
analysis. Approximately one-third of uninfected parti-
cipants (35%, n¼ 225) were common to both the
short- and long-term analyses.
Participant characteristics
At the ‘before’ visit, women who ultimately became
HIV infected were less likely than women remaining
HIV negative to be from Uganda (36 vs 56%),
although the proportion recruited from high-risk set-
tings in Uganda was similar (11 vs 10%) (Table 1).
Half of all participants were employed, and most
(76–83%) lived with their primary partner. Mean
age (25.0 vs 25.5 years), mean age at coital debut
(17.5 years in both groups) and mean years of educa-
tion (9.1 for both groups) were similar between par-
ticipants who ultimately became HIV infected and
those remaining uninfected. Alcohol or drug use
during sex in the last 3 months was rare (3–4%),
and commercial sex was also uncommon (1% in
both groups). Women who became HIV infected
were more likely than women remaining uninfected
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to report multiple partnerships in the last 3 months
(7 vs 3%) and to have a higher mean number of
nights in the last month that the partner spent
away from home (8.0 vs 6.7 nights).
Changes in coital frequency and frequency of
unprotected sex
We first examined changes in the number of
HIV-infected and uninfected participants who
reported any sex acts in a typical month. The
number of women engaging in sex in both groups
declined slightly. Before HIV diagnosis, 144 partici-
pants (95%) who ultimately became HIV infected
reported at least one act in a typical month; 12–16
months after notification of HIV-positive status,
137 women (91%) reported at least one act in a
typical month. Of uninfected women, 642 (99%)
reported at least one act before the anchor visit,
compared with 623 women (96%) who reported at
Table 1 Selected participant characteristics reported 2–6 months before HIV diagnosis (HIV-infected women) or anchor
visit (uninfected women)
Short-term analysis Long-term analysis
HIV infected HIV uninfected HIV infected HIV uninfected
Characteristic n¼ 158a n¼ 650b (%) n¼ 151a (%) n¼ 650b (%)
Country/referral population
Uganda
Family planning and MCH clinic 36 (23) 291 (45) 38 (25) 299 (46)
STD clinics, sex worker networks, military wives 18 (11) 59 (9) 16 (11) 62 (10)
Zimbabwe 104 (66) 300 (46) 97 (64) 289 (45)
Employed
Yes 80 (51) 325 (50) 75 (50) 326 (50)
No 78 (49) 325 (50) 76 (50) 324 (50)
Cohabit with primary partner
Yes 122 (77) 534 (82) 115 (76) 538 (83)
No 36 (23) 116 (18) 36 (24) 112 (17)
Alcohol or drug use during sex in last 3 months
Yes 6 (4) 15 (2) 6 (4) 19 (3)
No 152 (96) 635 (98) 145 (96) 631 (97)
Current contraceptive method
COC 43 (27) 234 (36) 45 (30) 218 (34)
DMPA 65 (41) 239 (37) 64 (42) 258 (40)
COC and DMPA 1 (1) 2 (0.3) 0 (0) 3 (1)
Non-hormonal method 49 (31) 175 (27) 42 (28) 171 (26)
Commercial sex in last 3 months
Yes 2 (1) 5 (1) 2 (1) 5 (1)
No 156 (99) 645 (99) 149 (99) 645 (99)
Number of sex partners in last 3 months
0 partners 6 (4) 12 (2) 7 (5) 4 (1)
1 partner 142 (90) 629 (97) 134 (89) 628 (97)
52 partners 10 (6) 9 (1) 10 (7) 18 (3)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 24.9 (4.1) 25.6 (4.4) 25.0 (4.2) 25.5 (4.5)
Age at coital debut (years) 17.6 (2.2) 17.5 (2.5) 17.5 (2.2) 17.5 (2.7)
Education (years) 9.2 (2.5) 9.2 (3.0) 9.1 (2.5) 9.1 (3.1)
Partner nights away in last 30 days 8.3 (11.1) 6.8 (10.7) 8.0 (10.9) 6.7 (10.7)
a137 HIV-infected women are common to the short- and long-term analyses.
b225 HIV-uninfected women are common to both the short- and long-term analyses.
MCH¼maternal-child health; STD¼ sexually transmitted disease; COC¼ combined oral contraceptive pills; DMPA¼depot
medroxyprogesterone acetate.
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Table 2 Coital frequency of and condom use by HIV-infected and HIV-uninfected participants
Short-term analysis Long-term analysis
HIV positive HIV negative HIV positive HIV negative
Sexual behaviour n (%) n (%) n (%) n (%)
All women
No sex actsa
Beforeb 7 (4) 13 (2) 7 (5) 8 (1)
Afterb 15 (10) 20 (3) 14 (9) 27 (4)
5 1 sex acta
Before 151 (96) 637 (98) 144 (95) 642 (99)
Afterb 143 (91) 630 (97) 137 (91) 623 (96)
P-valuez 0.10 0.14
Among women with 51 sex acta,c
No unprotected actsa
Before 42 (28) 142 (22) 37 (26) 156 (24)
After 63 (44) 117 (19) 60 (44) 134 (22)
51 unprotected acta
Before 109 (72) 495 (78) 107 (74) 486 (75)
After 80 (56) 513 (81) 77 (56) 489 (79)
P-valuez <0.01 <0.01
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Among women with 51 unprotected acta
Total actsa
Before 20.8 (58.7) 14.0 (10.2) 19.9 (59.2) 14.9 (12.3)
After 13.9 (21.1) 13.8 (9.6) 9.5 (7.2) 14.2 (11.9)
Unprotected actsa
Before 11.9 (12.5) 11.7 (8.8) 11.2 (11.7) 11.8 (10.4)
After 8.7 (6.8) 11.5 (8.7) 7.0 (6.0) 12.0 (11.0)
Percentage of acts that are unprotecteda
Before 77.0 (30.4) 86.5 (25.2) 78.9 (29.5) 84.1 (27.7)
After 78.4 (31.7) 86.5 (25.5) 78.5 (29.8) 87.1 (25.0)
aIn a typical month in the last 3 months.
bBefore and after notification of HIV-positive status (HIV-infected women) or anchor visit (uninfected participants).
cDenominator for percentages is women with 51 sex act.
zP-values obtained using McNemar’s test.
Table 3 ZINB models assessing changes in number of unprotected sex acts in a typical month following notification of


















of UPSA 95% CI
Short term HIV positive 2.03 1.29–3.20 0.72 0.56–0.93 1.55 0.91–2.66 0.71 0.55–0.91
HIV negative 0.77 0.63–0.94 0.98 0.91–1.06 0.77 0.63–0.95 0.98 0.91–1.06
Long term HIV positive 2.19 1.28–3.74 0.60 0.44–0.81 1.99 1.12–3.53 0.62 0.45–0.84
HIV negative 0.84 0.67–1.05 1.01 0.92–1.12 0.82 0.64–1.04 1.02 0.92–1.12
aAll adjusted models control for age, country, recruitment population, prior STI during study and partner symptomatic of STI in
past 3 months.
ZI¼ zero-inflated; OR¼ odds ratio; UPSA¼unprotected sex acts; CI¼ confidence interval.
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least one act 12–16 months after the anchor visit
(Table 2).
We next examined whether the number of women
reporting any unprotected acts changed after testing.
Among HIV-infected women reporting at least one
act, the number who had at least one unprotected
act in a typical month declined substantially: before
notification of HIV-positive status, 107 participants
(74%) who ultimately became HIV infected reported
at least one unprotected act in a typical month; after
HIV diagnosis, 77 women (56%) reported at least one
unprotected act in a typical month. Uninfected
women showed little change: among those with
at least one act, 486 (75%) before the anchor visit,
compared with 489 women (79%) after the anchor
visit, reported at least one unprotected act in a typical
month (Table 2).
Among the subgroup reporting at least one unpro-
tected act in a typical month, we next examined
changes to the mean total number of acts, the mean
number of unprotected acts, and the proportion of
acts where condoms were not used in a typical
month (Table 2). HIV-infected women again showed
marked declines in their overall mean coital fre-
quency, but less substantial changes in the mean
number of unprotected acts and virtually no change
in the proportion of acts where condoms were used.
Before HIV diagnosis, HIV-infected women reporting
at least one unprotected act had a mean of 19.9 total
acts and 11.2 unprotected acts in a typical month;
they reported that condoms were not used in 79%
of acts. After diagnosis, HIV-infected women with at
least one unprotected act reported means of 9.5 total
acts and 7.0 unprotected acts in a typical month; the
proportion of acts where condoms were not used
was again 79%. In contrast, HIV-negative women
with at least one unprotected act reported a mean
of 14.9 total acts and 11.8 unprotected acts before
the anchor visit: very similar to the 14.2 mean total
acts and 11.0 mean unprotected acts reported after
the anchor visit (Table 2). The proportion of acts
where condoms were not used among uninfected
women was 84% prior to the anchor visit and 87%
afterwards.
Among women reporting at least one unprotected
act in a typical month at the ‘before’ visit, women
who ultimately became HIV infected did not differ
meaningfully from women who remained uninfected
in their mean number of unprotected acts (11.2 vs
11.8 acts) or the mean proportion of unprotected
acts (79 vs 84% unprotected).
Multivariable long-term models
Long-term changes in the number of unprotected
sex acts
In unadjusted analyses, HIV-positive women were
twice as likely to report that all sex acts were pro-
tected by condoms (in other words, zero acts were
unprotected) in a typical month after HIV diagnosis
compared with their pre-diagnosis visit (OR: 2.19,
95% CI: 1.28, 3.74). Uninfected women had some-
what lower odds of reporting that all acts in a typical
month were protected by condoms 12–16 months
after their anchor visit (OR: 0.84, 95% CI: 0.67,
1.05) compared with 2–6 months before the anchor
visit (Table 3).
HIV-infected women also had a 40% reduction (95%
CI: 19 to 56%) in the number of unprotected
acts in a typical month 12–16 months after notifica-
tion of HIV-positive status compared with the pre-
diagnosis period. Uninfected women did not change
their number of unprotected acts in a typical month
(1% increase, 95% CI: 8 to þ12%) following their
anchor visit.
We refit our models after adjusting for variables
that confounded associations with condom use (age,
country, recruitment population, prior STI during the
study and partner symptomatic of STI in the past
3 months). Adjusted measures of effect were similar
to unadjusted estimates (Table 3).
Long-term changes in the proportion of
unprotected sex acts
Inclusion of an offset variable for the total number
of acts did not have a large influence on the logistic
portion of the unadjusted or adjusted models, but the
NB portion of the models was affected (Table 4).
Table 4 ZINB models assessing changes in proportion of unprotected sex acts in a typical month following notification of


















of UPSA 95% CI
Short term HIV positive 2.11 1.31–3.39 0.98 0.86–1.12 1.66 0.95–2.91 0.96 0.83–1.12
HIV negative 0.74 0.60–0.90 0.99 0.96–1.02 0.73 0.59–0.90 1.00 0.97–1.03
Long term HIV positive 2.32 1.38–3.90 0.96 0.85–1.10 2.17 1.23–3.83 0.93 0.82–1.06
HIV negative 0.83 0.67–1.04 1.04 1.00–1.08 0.82 0.65–1.04 1.05 1.01–1.09
aAll adjusted models control for age, country, recruitment population, prior STI during study and partner symptomatic of STI in
past 3 months.
ZI¼ zero-inflated; OR¼ odds ratio; UPSA¼unprotected sex act; CI¼ confidence interval.
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After diagnosis, HIV-infected women had virtually no
reduction in the proportion of acts where condoms
were not used (4% reduction, 95% CI: 15 to
þ 10%). Uninfected women similarly had no mean-
ingful change (4% increase, 95% CI: 0 to þ 8%).
Adjustment for confounding variables did not sub-
stantially alter the proportion of acts where condoms
were not used for HIV-infected or uninfected women
(Table 4).
Discussion
In this analysis, women who were notified that
they were HIV infected modified their behaviour.
Although most did not abstain altogether from
coitus, HIV-infected participants were more likely to
report that all acts were protected by condoms, and
they reduced their absolute number of unprotected
acts. However, the proportion of acts where condoms
were not used was nearly unchanged and, ultimately,
more than half of HIV-positive women still reported
some unprotected sex a year after diagnosis. In con-
trast, women who remained HIV uninfected exhibited
few changes over equivalent follow-up periods. These
findings are in agreement with the one existing pub-
lication (to our knowledge) that compares African
women’s condom use from the period prior to, and
following, notification of HIV status. That study docu-
mented that women testing positive for HIV reported
increased consistent condom use within their primary
partnerships 3 years later, but that women who tested
negative did not significantly change their condom
use behaviour.6
From a public health perspective, a reduction in the
number of unprotected acts is more important than
an increase in the proportion of acts where condoms
were used (unless, of course, the proportion where
condoms were used reaches 100%). Sexual transmis-
sion of HIV occurs through an act of unprotected sex.
Whether that act is a large or small proportion of all
acts is less relevant. Because HIV-infected women in
this cohort markedly reduced their number of unpro-
tected acts, susceptible partners of HIV-infected
women likely faced reduced HIV risk.
The decline in number of unprotected acts among
HIV-infected women may be due to factors other than
intentional risk-reduction behaviour change. The visit
2–6 months prior to HIV diagnosis (the ‘before’ visit)
occurred around the time of HIV acquisition, when
women may have engaged in behaviour that was risk-
ier than their normal behaviour. Apparent reductions
in risk following notification of HIV infection may
simply be a return to more typical behaviour. In addi-
tion, women who disclosed HIV status to their part-
ners may have experienced relationship dissolution
and consequent reductions in overall coital frequency
and numbers of unprotected acts (we unfortunately
did not collect data on disclosure to partners).
Our analysis has a number of strengths. Because we
systematically captured women’s condom use prior to
diagnosis, our measure was not biased by women’s
knowledge of their status or the presence of symp-
toms that may have prompted them to modify
condom use. Secondly, much of the research examin-
ing behaviour change after HIV acquisition has been
conducted among specialized, high-risk populations
(e.g. sex workers or truckers). HC-HIV had a small
proportion of participants (9–11%) recruited from
STD clinics, including some sex workers. However,
our focus on general population women makes the
results more generalizable to African women from
the general population, at whom HIV-prevention
interventions are currently targeted. Finally, earlier
studies tracking changes in condom use typically
assessed intervention effectiveness for 43 months.
Our long-term analysis demonstrates that behaviour
changes may be sustained 41 year after testing
positive.
Our analyses also suffer from several limitations.
Most importantly, the number of unprotected acts
was self reported and may have been influenced
by recall and social desirability biases. Because mis-
reporting could be differential by HIV status, the
resulting bias could lead to inflated or attenuated
effect estimates. Secondly, we do not know which
participants had HIV-infected partners. If women
knew that their partners were already HIV positive,
they would likely lack incentive to reduce unprotected
sex upon learning of their own positive status.
Thirdly, we did not analyse sexual behaviour data
separately by partner type (primary vs non-primary).
Few women had multiple partners––at the ‘before’
visit, 6–7% of women ultimately becoming HIV-
infected and 1–3% of participants remaining unin-
fected––and we expect any bias to be minimal.
Finally, our measures capture the short- and long-
term impact of being diagnosed with HIV in the lim-
ited context of repeat counselling and provision of
condoms. All women, regardless of HIV status,
received similar counselling messages and access to
free condoms. We therefore believe that the behav-
iour changes in HIV-positive women are motivated
more from knowledge of HIV-positive status than
just ongoing counselling, but we acknowledge that
the long-term durability of those changes could be
due in part to the ongoing counselling. (In addition,
we cannot make a general statement about the
number of counselling sessions; some women had
participated in HC-HIV for41 year prior to their diag-
nosis or anchor visit, and others had been in the
study for only 3 months). For HIV-negative women,
identifying the long-term effect of a single test is dif-
ficult because these women continued to be tested
(and undergo counselling, and receive condoms)
every 3 months. Despite this limitation, comparing
behaviour changes over time in women remaining
HIV negative was critical because it allowed us to
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evaluate secular trends that may have occurred over
the course of the study period.
Given that these analyses were conducted on data
collected during a study of hormonal contraceptive
use, the effect of contraceptive decisions on changes
in condom use is important to consider: could
condom use have increased after HIV diagnosis as a
contraceptive choice, or did some women start using
more effective hormonal contraception after HIV diag-
nosis and therefore stop using condoms? In fact, the
primary change seen in HIV-infected women was not
an increase in condom use but rather a reduction in
both the overall number of sex acts and in the
number of unprotected acts. In separate analyses cur-
rently under review (data not shown), among women
not using hormonal methods just before HIV diagno-
sis, few women starting using hormonal methods
after they received an HIV-positive diagnosis.
We undertook these analyses to explore a funda-
mental assumption in HIV prevention interven-
tions—that provision of counselling and condom
supplies can induce individuals to reduce their risk
behaviour. Through both reductions in the number
of women engaging in unprotected sex and through
declines in overall coital frequency, HIV-infected
Ugandan and Zimbabwean women in this cohort
reduced the risk of HIV transmission to susceptible
partners and sustained these behaviour changes 41
year after HIV diagnosis. The lack of behaviour
change among uninfected women suggests that
repeated risk reduction counselling and free condoms
are not sufficient to reduce unprotected sex in this
group. However, because women remaining HIV
negative also did not increase their risk taking with
regard to condom use, our findings do not support the
concern that a negative HIV result may be perceived
as an endorsement of risky behaviour.
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